complete routine immunization as a prerequisite for student enrollment is the government's strategy to eradicate measles and rubella by 2023
They are set to be destroyed immediately.
"This vaccine is not intended for the general public but for people, who are at high risk, or for health workers," Head of the IDI Monkeypox Task Force Hanny Nilasari
The circular letter is effective starting on August 25, 2022.
The decision was also based on recommendation issued by the Indonesian Technical Advisory Group on Immunization (ITAGI).
A decision to this effect was made during a limited cabinet meeting chaired by President Joko Widodo (Jokowi) at Merdeka Palace, Jakarta, on Monday.
"Currently, we are doing clinical trials for the primary vaccine first. The possible priority is for the need for a booster (third dose) and for children. We still lack the supply of vaccines for children."
Vaccine distribution in the country declined quite sharply.
Since March 24 until May 12, or for eight weeks, the (COVID-19) reproduction rate has been consistent at the score 1. This means that for eight weeks, the COVID-19 pandemic (in Indonesia) has been brought under control
Only 27.2 percent of senior citizens across the country have received COVID-19 booster shot.
Ministry of Health has announced that Sinovac vaccine will be used as a COVID-19 booster shot.
The HPV vaccination program is included in the ranks of mandatory vaccinations in Indonesia, such as COVID-19 and complete basic immunization, the minister stated.
Travelers from Singapore that have stayed in the country for at least 14 days as well as received the second or third dose of vaccine are required to bring a negative rapid test antigen result taken 24 hours prior
It raises a question: is getting vaccinated allowed during fasting?
Pre-existing condition shouldnt prevent the elderlies to get their COVID-19 vaccine doses even though they have to ensure the conditions are controlled.
While the majority of senior citizens in Jakarta have been fully-vaccinated, their participation in booster rollout is still currently low and needs to be improved.
Volunteers taking part in Merah Putih vaccine trial will be monitored for a year after they received the shot.
BPOM issues emergency use authorization (UEA) upon evaluation on the safety and efficacy aspects of Sinopharm vaccine, which will be used as homologous booster.
The Agency issued emergency use authorization (UEA) after evaluation with experts found the vaccines to have met the standards and requirements.
"Based on Our World in Data, as of January 4, 2022, Indonesia has injected 281,574,183 doses of the COVID-19 vaccine. This has brought Indonesia to rank as one of the five countries with the highest vaccination coverage in the world"
